Search research articles
Contact Us
Filters
Showing results (21-30 of 177) with videos related to
Page
of 18
Sort By:
British Journal of Haematology
|
November 24, 2018
Evolution of multiple myeloma treatment practices in Europe from 2014 to 2016
Marc S Raab, Leah Fink, Paul Schoen, et al.
Leukemia
|
July 7, 2018
Cytogenetic abnormalities in monoclonal gammopathy of undetermined significance
Maximilian Merz, Thomas Hielscher, Korbinian Hoffmann, et al.
European Journal of Medicinal Chemistry
|
March 5, 2017
Synthesis and formulation studies of griseofulvin analogues with improved solubility and metabolic stability
Asger B Petersen, Nikolaj S Andersen, Gleb Konotop, et al.
European Journal of Haematology
|
June 20, 2024
Retrospective study on pomalidomide-PACE as a salvage regimen in aggressive relapsed and refractory multiple myeloma
Deniz Gezer, Melanie Schmitt Nogueira, Martin Kirschner, et al.
American Journal of Hematology
|
August 11, 2016
Baseline characteristics, chromosomal alterations, and treatment affecting prognosis of deletion 17p in newly diagnosed myeloma
Maximilian Merz, Thomas Hielscher, Anja Seckinger, et al.
BMJ Open
|
July 16, 2020
Novel risk stratification algorithm for estimating the risk of death in patients with relapsed multiple myeloma: external validation in a retrospective chart review
Roman Hájek, Sebastian Gonzalez-McQuire, Zsolt Szabo, et al.
Annals of the Rheumatic Diseases
|
June 1, 2025
One-year remission of therapy-resistant SLE after a single course with the bispecific CD3: BCMA antibody teclistamab, but induction of a non-infectious Crohn's-like inflammatory bowel disease
Hanns-Martin Lorenz, Wolfgang Merkt, Juliane Brandt, et al.
Blood Cancer Journal
|
August 27, 2024
Longitudinal assessment of established risk stratification models in patients with monoclonal gammopathy of undetermined significance
Kosima Zuern, Thomas Hielscher, Annika Werly, et al.
European Journal of Haematology
|
May 22, 2019
Understanding mortality in multiple myeloma: Findings of a European retrospective chart review
Mohamad Mohty, Michele Cavo, Leah Fink, et al.
International Journal of Cancer
|
April 10, 2020
B-cell maturation antigen-specific chimeric antigen receptor T cells for multiple myeloma: Clinical experience and future perspectives
Leopold Sellner, Fuli Fan, Nicola Giesen, et al.
Page
of 18
Search research articles
Search
Showing results (21-30 of 177) with videos related to
Sort By:
Page
of 18
British Journal of Haematology
|
November 24, 2018
Evolution of multiple myeloma treatment practices in Europe from 2014 to 2016
Marc S Raab, Leah Fink, Paul Schoen, et al.
Leukemia
|
July 7, 2018
Cytogenetic abnormalities in monoclonal gammopathy of undetermined significance
Maximilian Merz, Thomas Hielscher, Korbinian Hoffmann, et al.
European Journal of Medicinal Chemistry
|
March 5, 2017
Synthesis and formulation studies of griseofulvin analogues with improved solubility and metabolic stability
Asger B Petersen, Nikolaj S Andersen, Gleb Konotop, et al.
European Journal of Haematology
|
June 20, 2024
Retrospective study on pomalidomide-PACE as a salvage regimen in aggressive relapsed and refractory multiple myeloma
Deniz Gezer, Melanie Schmitt Nogueira, Martin Kirschner, et al.
American Journal of Hematology
|
August 11, 2016
Baseline characteristics, chromosomal alterations, and treatment affecting prognosis of deletion 17p in newly diagnosed myeloma
Maximilian Merz, Thomas Hielscher, Anja Seckinger, et al.
BMJ Open
|
July 16, 2020
Novel risk stratification algorithm for estimating the risk of death in patients with relapsed multiple myeloma: external validation in a retrospective chart review
Roman Hájek, Sebastian Gonzalez-McQuire, Zsolt Szabo, et al.
Annals of the Rheumatic Diseases
|
June 1, 2025
One-year remission of therapy-resistant SLE after a single course with the bispecific CD3: BCMA antibody teclistamab, but induction of a non-infectious Crohn's-like inflammatory bowel disease
Hanns-Martin Lorenz, Wolfgang Merkt, Juliane Brandt, et al.
Blood Cancer Journal
|
August 27, 2024
Longitudinal assessment of established risk stratification models in patients with monoclonal gammopathy of undetermined significance
Kosima Zuern, Thomas Hielscher, Annika Werly, et al.
European Journal of Haematology
|
May 22, 2019
Understanding mortality in multiple myeloma: Findings of a European retrospective chart review
Mohamad Mohty, Michele Cavo, Leah Fink, et al.
International Journal of Cancer
|
April 10, 2020
B-cell maturation antigen-specific chimeric antigen receptor T cells for multiple myeloma: Clinical experience and future perspectives
Leopold Sellner, Fuli Fan, Nicola Giesen, et al.
Page
of 18